baseline hematologic indices, were an independent predictor of adverse cardiac events in patients with STEMI. In contrast, Sulaiman et al 16 reported that admission leukocyte count was an independent risk factor for in-hospital cardiogenic shock and mortality in patients with acute coronary syndrome. In another study, in patients with STEMI, preprocedural high NLR was significantly associated with both stent thrombosis and higher mortality rates. 17 There are no established cutoff values for the NLR. Azab et al 2 reported that patients with non-STEMIs with an average NLR >4.7 had increased mortality. Horne et al 7 proposed an NLR >4.71 as a cutoff value for patients with stable CAD. In the study of Park et al, 14 the cutoff value was 5.44. Those studies have mainly used the highest quartile of NLR as the cutoff value. In contrast, in the Pan et al and Ayca et al studies, 8, 17 the NLR cutoff value for predicting in-hospital mortality was derived from receiver-operating characteristic curve analysis with threshold values of 5.9 and 4.9, respectively.
On the other hand, a few studies have reported a higher prevalence of previous PCI in the lowest admission NLR tertile and suggested that anti-inflammatory actions of some medications after PCI, such as clopidogrel and statins, lower the NLR. 2, 18 The NLR has been also associated with contrastinduced nephropathy, which is an emerging important issue in patients receiving contrast media. 19, 20 The NLR, measured at admission, [8] [9] [11] [12] [13] 18 24 hours after PCI, 14 immediately before PCI and 1, 2, 3, 5, and 30 + 2 days later 15 or calculated as an average 2 or maximum value 21 has been found to be an independent predictor of mortality and adverse outcomes. A study of 692 Chinese patients with STEMI 22 found that the NLR measured at admission, 24, and 72 hours after admission, before discharge, and both maximum and average NLR during hospitalization all predicted mortality. In STEMI, the peripheral leukocyte count usually increases within 2 hours after the onset of chest pain and peaks 2 to 4 days after infarction returning to normal in 1 week. 23 The shorter life span (around 7 hours) with a rapid turnover of neutrophils raises the question of which NLR should be used (eg, admission, in-hospital, maximum, or average NLR). Possibly, serial measurement of NLRs and evaluation of any NLR (admission, in-hospital, maximum, or average) would be useful for the prediction of mortality.
In conclusion, since the association between the NLR and the cardiovascular diseases was reported in 2005, several studies supported the ability of the NLR to predict the risk of subsequent mortality in different patient populations. 24 However, the NLR is not included in any vascular risk scoring system. Is it time to decide if there is something new regarding the NLR?
